sonidegib
Showing 1 - 8 of 8
Locally Advanced Basal Cell Carcinoma Trial in Brescia (Sonidegib)
Recruiting
- Locally Advanced Basal Cell Carcinoma
- Sonidegib
-
Brescia, ItalyAsst Degli Spedali Civili Di Brescia
Aug 3, 2022
Basal Cell Carcinoma, Basal Cell Carcinoma of Skin, Site Unspecified, Skin Cancer Trial in North Sydney (drug, procedure, other)
Recruiting
- Basal Cell Carcinoma
- +3 more
- Sonidegib
- +3 more
-
North Sydney, New South Wales, AustraliaMelanoma Institute Australia
Jun 9, 2022
Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma Trial in Netherlands (Vismodegib,
Recruiting
- Basal Cell Carcinoma
- +10 more
- Vismodegib
- Sonidegib
-
Nijmegen, Gelderland, Netherlands
- +7 more
Jul 14, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Laboratory Biomarker Analysis, Lenalidomide,
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Dec 1, 2021
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +38 more
- Pembrolizumab
- Sonidegib
-
Scottsdale, Arizona
- +2 more
Aug 27, 2021
Medulloblastoma Trial in Zürich (Sonidegib, Cisplatin, Lomustine)
Not yet recruiting
- Medulloblastoma
- Sonidegib
- +4 more
-
Zürich, SwitzerlandUniversity Hospital zurich
May 20, 2020
Carcinoma, Basal Cell, Recurrent Skin Cancer, Skin Tumors Trial in Stanford (Buparlisib, Sonidegib)
Terminated
- Carcinoma, Basal Cell
- +3 more
- Buparlisib
- Sonidegib
-
Stanford, CaliforniaStanford University School of Medicine
Jan 10, 2019